Zynerba Pharmaceuticals Inc Ipo

Zynerba pharmaceuticals inc ipo

Ray Mannion
Vice President, Manufacturing

Ray Mannion has served as our Vice President of Manufacturing since April 2017.

Best options for backing up photosgroung photograpy

Mr. Mannion has more than 35 years of international manufacturing, operations and engineering experience in the pharmaceutical, medical devices and electrical connection systems industries.

Zynerba Pharmaceuticals, Inc. - ZYNE Stock Chart Technical Analysis for 12-16-2019

Prior to Zynerba, he was Senior Director, Third Party Operations for Teva Pharmaceuticals Inc. (NYSE: TEVA) where he successfully managed the production scale up for the commercial launch of the Zecuity® migraine patch while also managing all technical aspects of the project.

Zynerba pharmaceuticals inc ipo

In addition to his activities with Zecuity, he led a Supplier Relations Team where he collaborated with Teva stakeholders in managing a portfolio of key strategic suppliers in the areas of contract negotiations, product supply, new product launches and product serialization. Prior to Teva, Mr. Mannion held the position of Vice President of Commercial Manufacturing at NuPathe (NASDAQ: PATH) where he led the production scale up and process validation efforts for the Zecuity migraine patch.

Zynerba pharmaceuticals inc ipo

Prior to NuPathe, Mr. Mannion served as the Vice President of Operations for PuriCore, Inc., where he managed internal and external manufacturing, engineering, quality assurance & regulatory affairs, supply chain, customer service and field service for PuriCore’s US and UK operations.

Zynerba pharmaceuticals inc ipo

In addition, Mr. Mannion has held various Operations, Engineering and Manufacturing roles with Animas Corporation, Kensey Nash Corporation and AMP Incorporated.

Zynerba pharmaceuticals inc ipo

Mr. Mannion received a B.S. in Industrial Engineering from Rutgers University, New Brunswick, NJ and an M.B.A from Shippensburg University, Shippensburg, PA.

Zynerba pharmaceuticals inc ipo